Clinical Trial Update: Phase 2 Clinical Trial of CartiLife® in the United States [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for CartiLife in the United States; current status is unknown for articular cartilage defect and degeneration.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Articular Cartilage Defect
• Articular Cartilage Degeneration

Drugs mentioned

• CartiLife

Snippet

Sponsor: Biosolution Co., Ltd. | Conditions: Articular Cartilage Defect, Articular Cartilage Degeneration | Phase 2 | Status: UNKNOWN